Global /China /Healthcare /Medical Care Facilities /2325
chevron_leftBack
Yunkang Group Ltd. logo

Yunkang Group Ltd.

2325
SHEK: 2325 Delayed
0.7300HKD -5.2%
0.0932 USD
As of 8 June 2026, Yunkang Group Ltd. has a market cap of $58.28M USD, ranking #29481 globally and #6062 in China. It ranks #2671 in the Healthcare sector, and #320 in the Medical Care Facilities industry.
Global Rank
29481
Country Rank
6062
Sector Rank
2671
Industry Rank
320
Key Stats
Market Cap
$58.28MUSD
456.57M HKD
Enterprise Value
-$84.39MUSD
-661.25M HKD
Revenue (TTM)
$85.42MUSD
669.23M HKD
EBITDA (TTM)
$20.74MUSD
162.54M HKD
Net Income (TTM)
$414.77KUSD
3.25M HKD
EBITDA Margin
24%
Profit Margin
0.5%
PE Ratio
140.5
PS Ratio
0.7
PB Ratio
0.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Yong Zhang open_in_new
Employees
1,146
Founded
2008
Website
yunkanghealth.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-5.2% -2.7% -11% -21% -26% -76%

News

Loading...

Markets

Exchange Ticker Price
Hong Kong Stock Exchange
MIC: XHKG
PRIMARY
2325
云康集团有限公司 Ordinary Shares
ISIN: KYG9889T1067
Shares Out.:
585.345M1 Shares Float: 177.867M2
TV:
SA:
YF:
GF:
BA:
MS:
0.7300 HKD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Yunkang Group Ltd.

Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests; and genetic reproduction and screening tests. In addition, the company offers routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. Further, it provides diagnostic testing services for financial institutions and insurance companies, including personalized diagnostic testing, medical report consultation, and hospital referral services; information technology, medical logistics, and reagent and medical equipment procurement; healthcare technology development; and project investment services. The company provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.

Similar Companies

Industry: Medical Care Facilities (China)
Name
Market Cap diff.
PE
$15.02B
101.77B CNY
26K%
30.1
$3.02B
20.46B CNY
5K%
75.1
$2.95B
23.07B HKD
5K%
54.2
$2.86B
19.35B CNY
5K%
38.6
$1.91B
12.97B CNY
3K%
218.8
$1.87B
12.65B CNY
3K%
-
Industry: Medical Care Facilities (Global)
Name
Market Cap diff.
PE
$232.18B
852.82B AED
398K%
44.1
$96.73B
166K%
14.9
$26.68B
22.97B EUR
46K%
15.0
$25.58B
22.02B EUR
44K%
24.9
$22.48B
84.42B SAR
38K%
35.2
$21.13B
36K%
24.6
chevron_leftBack